NFKB1 and triple-negative breast carcinoma: Additionally, it was reported that a series of tumorigenesis-related genes could be regulated by pSTAT3 and NF-κB, either synergistically or individually [33], and STAT3/NF-κB signaling targeting could sensitize triple-negative breast cancer cells to cisplatin [37].